Literature DB >> 9526902

Parenteral triamcinolone acetonide: an alternative corticosteroid for the treatment of asthma.

S Veeraraghavan1, O P Sharma.   

Abstract

Corticosteroids are effective in reducing the airway inflammation and controlling the symptoms of asthma. Many patients with chronic, severe asthma are steroid-dependent, requiring daily oral corticosteroids. Although corticosteroids may be effective, many patients suffer from their intolerable side effects. Various medications have been used as steroid-sparing agents in patients who suffer from the side effects of long-term high-dose steroids. While drugs like methotrexate and cyclosporine are promising, none have clearly been shown to be beneficial in most patients with asthma. The long-acting parenteral steroid triamcinolone acetonide has been tested by various investigators in these patients for over 20 years. Intramuscular triamcinolone appears to beneficial, with no significant increase in adverse effects.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9526902     DOI: 10.1097/00063198-199801000-00006

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  2 in total

1.  Evidence for different subgroups of difficult asthma in children.

Authors:  D N Payne; N M Wilson; A James; H Hablas; C Agrafioti; A Bush
Journal:  Thorax       Date:  2001-05       Impact factor: 9.139

Review 2.  Antiasthmatic drug delivery in children.

Authors:  Elizabeth Biggart; Andrew Bush
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.